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Adult stem cells are responsible for the cellular turnover of many organs, and an impairment in their function
leads to aging and disease. In efforts to reverse the process of tissue stem cell aging, we speculate on the
promise and challenges of in vivo direct reprogramming strategies.Aging correlates with a decline in the
function of the adult stem cells (i.e.,
somatic stem cells) present in many
organs of an adult mammal. A decrease
in the stem cell pool and/or a restriction
in the somatic stem cell differentiation
potential affects tissue homeostasis and
regeneration. Here, we discuss the
possibility of replacing or rejuvenating
dysfunctional adult stem cells from an
aged tissue or organ using a direct re-
programming approach in situ.
Limitations of Generating
Differentiated Somatic Cells
for Anti-Aging Purposes
The ability to induce pluripotency in
somatic cells has heralded a new era in
the field of regenerative medicine,
because induced pluripotent stem cells
(iPSCs) specific to individual patients
could provide an unlimited source of
specialized cell types for replacing
diseased or aged tissues. However,
several technical problems must be
resolved before safely translating the
iPSC technology to the clinic. For thera-
peutic purposes, the iPSCs must be
differentiated into the required cell types.
Currently available differentiation pro-
tocols aim to recapitulate in vitro the
embryonic events that occur in the early
embryo in vivo. However, the underlying
developmental mechanisms are not
well understood, making their faithful
modeling in vitro a difficult undertaking
and preventing the derivation of sufficient
quantities of transplantable cells. In addi-
tion to transplantation and proper en-
graftment, the risk for teratoma formationremains a major issue with somatic cells
differentiated from iPSCs (Cohen and
Melton, 2011).
The reprogramming of somatic cells
into iPSCs entails the use of a set of
specific transcription factors that can
establish a pluripotent program in a differ-
entiated cell. This method of reprogram-
ming suggests that other cell fates could
be induced if the right transcription factor
cocktail is used. Recent studies have
indeed shown that specific transcription
factor combinations can be used to
convert fibroblasts directly into neurons,
cardiomyocytes, and hepatocytes, by-
passing a pluripotent intermediate and
essentially removing the risk for teratoma
formation. The cell types generated by
such direct lineage reprogramming typi-
cally exhibit an immature phenotype
resembling that of fetal or neonatal cells.
Nevertheless, these cells might acquire
a fully functional and mature profile after
engraftment into the host and subsequent
exposure to the appropriate environ-
mental cues (Cohen and Melton, 2011).
However, terminally differentiated cells,
such as postmitotic neurons, do not
proliferate and cannot be expanded prior
to transplantation. Therefore, the genera-
tion of a sufficient number of cells for
ensuring a successful transplantation
remains a challenge.
A strategy that might circumvent this
obstacle is the direct reprogramming of
somatic cells into self-renewing somatic
stem cells. The low reprogramming
efficiency associated with this approach
would not limit the clinical applicability
of this strategy because the generatedCell Stem Cellcells would be able to proliferate. In addi-
tion, the somatic stem cells could be
transplanted into the host niche, where
endogenous stimuli could promote
acquisition of a fully mature phenotype.
Moreover, transplanted somatic stem
cells could self-renew and/or differentiate
into cells that would respond to inflam-
matory signals and migrate toward
damaged tissues, thus facilitating proper
engraftment for regenerative purposes.
Recently, we and others reported the
direct conversion of mouse fibroblasts
into self-renewing induced neural stem
cells (iNSCs) that could differentiate into
neurons, astrocytes, and oligodendro-
cytes, as reviewed in Zhou and Tripathi
(2012).
A successful direct reprogramming
strategy requires the use of culture con-
ditions that are optimal for the desired
cell type. However, such conditions have
not yet been established for all of the
specialized cell types of the adult
organism. To overcome this problem,
one could perform direct lineage conver-
sion in vivo, where the right environment
already exists to promote the survival of
the induced cells. As a proof of principle,
exocrine pancreatic cells have been
directly reprogrammed in vivo into b cells
(Zhou et al., 2008). Reprogramming in
situ circumvents the need to determine
culture conditions for the maintenance of
the induced cells in vitro, provides the
right niche for achieving a fully mature
and functional phenotype, and eliminates
the transplantation step. However, as in
the in vitro scenario, in vivo conversion
into somatic cells is limited by the10, June 14, 2012 ª2012 Elsevier Inc. 653
Figure 1. Potential Strategies for Restoring Stem Cell Function in Aged Organs and Tissues
(A) Stem cells contain a genetic modification that is transmitted to their progenitor and daughter cells. In this scenario, somatic cells located close to the niche and
not derived from the mutated adult stem cell would be reprogrammed by factors (e.g., expressed via viruses) into de novo stem cells.
(B) Stem cells contain an epigeneticmodification that is transmitted to the progenitors. In this case, progenitor or differentiated cells would be dedifferentiated into
stem cells, and the detrimental epigenetic marks would be erased.
(C) The stem cell transcriptional network is missing specific transcription factors that would be delivered specifically to the stem cells.
(D) Malfunction of the stem cells is due to an aged niche, which would be the target for the in vivo reprogramming.
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cess and by the nonproliferative nature
of many terminally differentiated cells.
Thus, the number of somatic cells directly
converted in vivo might not suffice to
rescue the tissue deficiency. This problem
could again, in principle, be overcome
by the direct conversion in vivo of differ-
entiated cells into proliferative tissue-
specific somatic stem cells. Therefore,
direct reprogramming in vivo into somatic
stem cells might potentially be able to
circumvent many of the obstacles that
stand in the way of being able to use
direct lineage reprogramming in a thera-
peutic setting.
Reprogramming In Vivo into
Somatic Stem Cells Could
Compensate for Tissue Aging
In theory, if tissue stem cells could be
generated from somatic cells in vivo using654 Cell Stem Cell 10, June 14, 2012 ª2012the right combination of factors, then the
in situ reprogrammed adult stem cells
could be used to ameliorate the effects
of an age-related decline in the stem cell
pool and/or a restriction in the stem cell
differentiation potential. Depending on
the mechanisms underlying the age-
related stem cell dysfunction, we have
divided the different strategies that could
be explored into genetic abnormalities,
epigenetic modifications, dysregulated
gene expression, and niche defects.
In the case of intrinsic genetic modifica-
tions in the adult stem cells (Figure 1A),
such as chromosomal translocations or
mutations, de novo somatic stem cells
would need to be generated. Because
daughter cells could also have inherited
the genetic alterations that are respon-
sible for the dysfunction, the progeny of
stem cells that need to be replaced could
not be the cells subjected to the directElsevier Inc.conversion. Therefore, somatic cells
located close to the stem cell niche that
are not derived from the damaged tissue
stem cells would be the target cell of
choice. Some cell types can present
advantages for the reprogramming
process that should be taken into consid-
eration. For instance, epithelial cells (e.g.,
keratinocytes) can be reprogrammed into
iPSCs more rapidly than cells from
a mesenchymal origin because they do
not need to undergo a mesenchymal-to-
epithelial transition step (Stadtfeld and
Hochedlinger, 2010). However, the poten-
tial impact of these parameters in the
direct conversion into somatic stem cells
needs to be investigated.
In another scenario (Figure 1B), adult
stem cell dysfunction could be caused
by epigenetic modifications (Pollina and
Brunet, 2011). In this case, progenitor
or daughter cells differentiated from the
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conversion, because the reprogramming
process would most likely reset the
epigenome, correcting the detrimental
modifications. Progenitor cells lack the
unlimited self-renewal activity of somatic
stem cells and are committed to differen-
tiation. However, somatic stem cells and
the progenitors derived from them have
very similar transcriptional networks. For
instance, neural stem cells and neural
progenitor stem cells both express Sox2
(Zhou and Tripathi, 2012). During the
reprogramming of NSCs into iPSCs,
Sox2 does not need to be exogenously
introduced, because it is already ex-
pressed by the NSCs, reducing the
number of reprogramming factors needed
(Stadtfeld and Hochedlinger, 2010). Thus,
we would suggest that the conversion of
progenitor or early-committed cells into
somatic stem cells might require fewer
transcription factors than conversion of
more differentiated cells because it could
take advantage of genes that are already
being endogenously expressed. Finally,
whereas the epigenetic memory in
somatic stem cells might be substantial
when reprogrammed from cells that orig-
inated from a different germ layer (Han
et al., 2012), using progenitor or early-
committed cells from the same lineage
as the initial target cell would minimize
its potential impact.
Another scenario would involve alter-
ations in the expression levels of specific
genes leading to an adult stem cell
malfunction (Figure 1C). For example,
deletion of the transcription factors
FoxO1, FoxO3, and FoxO4 reduces the
number of NSCs in the mouse adult brain,
impairing neurogenesis. Similar effects
are seen with deletion of the transcription
factor Tlx and the enzyme Telomerase. In
these situations, it is possible that forced
expression of single genes could improve
the performance of the aged adult stem
cells. Consistent with this idea, the over-
expression of Telomerase could restore
NSC self-renewal and neurogenesis in
aged telomerase-deficient mice (Pollina
and Brunet, 2011). The overexpression
of Tlx in NSCs also delayed the age-
associated NSC decline, but, in addition,
it led to the formation of glioma-like
lesions (Pollina and Brunet, 2011). As in
this case, many genes involved in stem
cell maintenance have also been related
to tumor formation. Considering that, todate, in vivo transplantation of somatic
stem cells generated by direct reprog-
ramming has not been associated with
any tumor formation, it appears that
induction of a de novo cell phenotype
may present a lower risk for tumorigen-
esis than the overexpression of single
genes in aged somatic stem cells
(e.g., Tlx).
In the generation of de novo somatic
stem cells, the old (i.e., aged) and young
stem cells will cohabitate in the same
niche. If the aged stem cells exhibit
a decline in self-renewal activity, we
would expect a dilution of the old stem
cell pool due to the higher proliferative
ability of the de novo-induced tissue
stem cells. In addition, the new stem cells
would be able to compensate for the
restricted differentiation potential of the
aged stem cells. However, the aged
stem cells exhibiting genetic alterations
cannot be eliminated from the stem cell
niche and would continue to accumulate
mutations, presenting a tumorigenic risk.
In the scenarios described above, the
decline in tissue homeostasis was caused
by intrinsic modifications in the stem
cells. But adult stem cells could also be
affected by extrinsic factors (Figure 1D).
The environment or stem cell niche plays
an essential role in regulating the self-
renewal and differentiation potential of
somatic stem cells. For instance, a reduc-
tion in the number of spermatogonial stem
cells (SSCs) with age is associated with
reduced fertility of male mice, suggesting
a decline in SSC self-renewal ability.
However, SSCs isolated from young
mouse testes could be serially trans-
planted multiple times into young recipi-
ents and could self-renew for a longer
time than the life span of a normal mouse
(Ryu et al., 2006). In this case, the prolifer-
ation decay is not intrinsic to the SSCs but
rather is induced by the aged environ-
ment. This phenomenon has been also
observed in other adult stem cells (e.g.,
hematopoietic stem cells). Therefore, the
tissue stem cell niche can be considered
to be one of the main players in prevent-
ing, reverting, and/or delaying stem cell
aging. At this point, we would like to spec-
ulate on the possibility of reprogramming
or rejuvenating the aged niche through
the overexpression of a minimum set of
genes. Unfortunately, very little is known
about the transcriptional networks gov-
erning the different cell types that formCell Stem Cella stem cell niche. Glial cell-line-derived
neurotrophic factor (GDNF) is a ligand
secreted by Sertoli cells that ensures the
self-renewal of SSCs in mouse testes.
Interestingly, aged testes show reduced
GDNF levels (Ryu et al., 2006), establish-
ing a connection between an alteration
in the SSC niche and a decline in SSC
proliferation ability. Although mice that
express GDNF ubiquitously are infertile
due to an inability of the SSCs to differen-
tiate (Meng et al., 2000), it would be
interesting to assess the effect of GDNF
overexpression solely by Sertoli cells on
aged SSC. Nevertheless, it seems unlikely
that only one gene could restore the
function of an aged stem cell niche. In
addition, the aging of the stem cell niche
is also affected by systemic factors, as
is evident from parabiosis experiments in
which circulating factors from the blood
of young mice can modify the stem cell
niche of old mice and can revert some
aging effects (studies that have been
recently reviewed in Wagers, 2012). In
those cases in which the main cause for
the dysfunctional niche relies on the
alteration of systemic factors, in situ
transcription-mediated reprogramming
of the aged adult stem cell niche would
not be the strategy of choice. Overall,
further knowledge in niche regulation is
needed to ascertain better strategies
for rejuvenating the stem cell environment
and, indirectly, restoring the somatic stem
cell function—a promising approach, yet
one fraught with many challenges.
Methods for Specifically Delivering
the Reprogramming Factors
For any transcription-factor-mediated
reprogramming approach, a robust tech-
nique for efficiently delivering reprogram-
ming factors to a specific cell type of
choice would be required but is currently
still lacking. The recent demonstration
that lentiviral vectors are able to recognize
and infect, in vivo, cells presenting with
specific cell-surface antigens is promising
(Anliker et al., 2010). However, lentiviral
vectors integrate into the host genome,
precluding their use in medical applica-
tions. Unfortunately, the efficiency of
the conversion process is significantly
compromised when using integration-
free methods, as demonstrated in iPSC
reprogramming experiments (Stadtfeld
and Hochedlinger, 2010). Therefore,
further efforts are needed to overcome10, June 14, 2012 ª2012 Elsevier Inc. 655
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the current reprogramming techniques.
Progress in the area of nanotechnology
may help develop systems that allow
efficient directed delivery of reprogram-
ming factors to regions within tissue
and organs.
Future Perspectives
From graying hair to a decline in neuro-
genesis, aging affects everyone. Though
an in vivo transcription-factor-mediated
approach cannot be considered as an
elixir for immortality, it could serve as the
basis for further discussion about tissue
stem cell rejuvenation. Future efforts
should be directed toward the character-
ization of the transcriptional networks of
tissue stem cells and their niches and
the development of delivery methods for
specific cell types. In addition, identifica-
tion of the molecular modifications that
stimulate adult stem cell longevity in656 Cell Stem Cell 10, June 14, 2012 ª2012response to environmental modifications
(e.g., dietary restrictions) would provide
crucial information for improving anti-
aging reprogramming strategies. The
challenges that lie ahead should be an
impetus for uncovering the missing links
in direct reprogramming and for restoring
stem cell function in aged cells.ACKNOWLEDGMENTS
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